EUVIMEDEUVIMED entdecken
Crossref

Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages

Tong Sun, Yamin Lin, Yun Yu, Siqi Gao, Xingen Gao, Hongyi Zhang, Kecan Lin, Juqiang Lin

Analytica Chimica Acta · 2024

DOI: 10.1016/j.aca.2024.342518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Tong Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China. Hauptthemen laut MEDLINE: Blood Proteins, Liver Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Xiamen University of Technology, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Surface-enhanced Raman scattering (SERS) technology have unique advantages of rapid, simple, and highly sensitive in the detection of serum, it can be used for the detection of liver cancer. However, some protein biomarkers in body fluids are often present at ultra-low concentrations and severely interfered with by the high-abundance proteins (HAPs), which will affect the detection of specificity and accuracy in cancer screening based on the SERS immunoassay. Clearly, there is a need for an unlabeled SERS method based on low abundance proteins, which is rapid, noninvasive, and capable of high precision detection and screening of liver cancer. RESULTS: Serum samples were collected from 60 patients with liver cancer (27 patients with stage T1 and T2 liver cancer, 33 patients with stage T3 and T4 liver cancer) and 40 healthy volunteers. Herein, immunoglobulin and albumin were separated by immune sorption and Cohn ethanol fractionation. Then, the low abundance protein (LAPs) was enriched, and high-quality SERS spectral signals were detected and obtained. Finally, combined with the principal component analysis-linear discriminant analysis (PCA-LDA) algorithm, the SERS spectrum of early liver cancer (T1-T2) and advanced liver cancer (T3-T4) could be well distinguished from normal people, and the accuracy rate was 98.5% and 100%, respectively. Moreover, SERS technology based on serum LAPs extraction combined with the partial least square-support vector machine (PLS-SVM) successfully realized the classification and prediction of normal volunteers and liver cancer patients with different tumor (T) stages, and the diagnostic accuracy of PLS-SVM reached 87.5% in the unknown testing set. SIGNIFICANCE: The experimental results show that the serum LAPs SERS detection combined with multivariate statistical algorithms can be used for effectively distinguishing liver cancer patients from healthy volunteers, and even achieved the screening of early liver cancer with high accuracy (T1 and T2 stage). These results showed that serum LAPs SERS detection combined with a multivariate statistical diagnostic algorithm has certain application potential in early cancer screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood ProteinsLiver NeoplasmsHumansDiscriminant AnalysisBiomarkersSpectrum Analysis, RamanPrincipal Component Analysis

Stichwörter der Autor:innen

Liver cancerLow-abundance proteinsSerumSurface-enhanced Raman spectroscopy

Substanzen

BiomarkersBlood Proteins

Autor:innen und Institutionen

  • School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China.
  • MOE Key Laboratory of Opto Electronic Science and Technology for Medicine and Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, Fujian, 350007, China.
  • College of Integrative Medicine, Laboratory of Pathophysiology, Key Laboratory of Integrative Medicine on Chronic Diseases (Fujian Province University), Synthesized Laboratory of Integrative Medicine, Fujian University…
  • Key Laboratory of Optoelectronic Devices and Systems of Guangdong Province and the Ministry of Education, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, China.
  • Department of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, China.
  • School of Opto-electronic and Communication Engineering, Xiamen University of Technology, Xiamen, Fujian, 361024, China. Electronic address: jqlin@t.xmut.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Xiamen University of Technology
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Sun, T., Lin, Y., Yu, Y., Gao, S., Gao, X., Zhang, H., Lin, K., & Lin, J. (2024). Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.342518

Vancouver

Sun T, Lin Y, Yu Y, Gao S, Gao X, Zhang H, et al. Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2024.342518

BibTeX
@article{Sun2024,
  author = {Sun, Tong and Lin, Yamin and Yu, Yun and Gao, Siqi and Gao, Xingen and Zhang, Hongyi and Lin, Kecan and Lin, Juqiang},
  title = {Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages},
  journal = {Analytica Chimica Acta},
  year = {2024},
  doi = {10.1016/j.aca.2024.342518}
}
Kostenlos starten →